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Abstract 
We investigated the antibacterial activity of Anemonia sulcata (Cnidaria, Anthozoa) tentacle and 
body acidic extracts. Biochemical purification consisted of first step on solid phase Sep-Pak C8 column 
followed by several HPLC runs on C18 column using different conditions. Anti-Micrococcus 
lysodeikticus activity has been detected in 40 % acetonitrile fractions. The resulting purified molecule 
from tentacles had a molecular mass determined by MALDI-TOF mass spectrum of 4946,299 Da and 
has been completely sequenced. Its aa sequence revealed identity with the Neurotoxin 2 (ATX-II), a 
Na+ channel blocking toxins. Consequently, ATX-II appeared to display a dual role as toxin and as 
antibacterial. 
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Introduction 
 
The sea anemone Anemonia sulcata is a 
widespread Mediterranean species. Sea anemones 
are generally poisonous animals that spend most of 
their lives in a sessile form. Capturing activities and 
defense mechanisms are strongly associated with 
toxin production (Ruppert and Barnes, 1994). The 
neurotoxin ATX II is a type 1 sodium channel toxin 
and consists of 47 amino acid residues, linked by 
three disulfide bridges. ATX II specifically binds to 
the sodium channel (site 3), thus delaying its 
inactivation during signal transduction; has a strong 
effect on crustaceans and insects and a weaker 
effect on mammals. These toxins specific for sodium 
channels have been thoroughly investigated also 
because they constitute a major fraction of the 
venom (Moran et al., 2009). 
Antimicrobial peptides are important defense 
molecules in marine invertebrates covering a broad-
spectrum of bacteria and fungi (Boman, 2003; Bulet 
et al., 2004). They are defined as molecules of less 
than 10 kDa characterized by immediate and rapid 
response to invading microorganisms (Bartlett et al., 
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2002). There is evidence that antimicrobial peptides 
are widespread in invertebrates (Chisholm and 
Smith, 1992), especially in tissues such as the gut 
and respiratory organs in marine invertebrates, 
subjected to a first exposure to pathogens. In spite 
of variations in structure and size, most of 
antimicrobial peptides are amphiphilic, displaying 
both hydrophilic and hydrophobic surfaces (Tincu et 
al., 2004). AMP are exciting candidates as new 
antibacterial agents due to their broad antimicrobial 
spectra, highly selective toxicities, and the difficulty 
for bacteria to develop resistance to these peptides 
(Boman, 1998; Lehrer and Ganz, 1999; Hancock et 
al., 2000). Therefore, AMPs from marine organisms 
represent a largely unexploited resource that can 
afford design of new antibiotics with broad-spectrum 
antimicrobial activity (Ovchinnikova et al., 2006). It is 
plausible that certain functional molecular motifs, 
such as amphipathic α-helices and β-sheets, would 
have featured predominantly in the arsenal 
employed by our distant eukaryotic ancestors. Over 
time, these would have diversified through mutation 
and selection pressure to produce the great variety 
of AMPs and other molecules (Smith et al., 2010). 
Several AMPs have been isolated from phylum 
of Cnidaria. Have been reported the purification of a 
40-residue AMP from the mesoglea of a scyphozoid 
jellyfish, Aurelia aurita (Ovchinnikova et al., 2006). 
The peptide was named aurelin and exhibited 
activity against gram-positive and gram-negative 
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Fig. 1 Tentacles and body acid extracts of Anemonia sulcata were loaded onto solid phase column (Sep-Pak C8). 
The resulting 10, 40 and 80 % acetonitrile fractions (10 μl) were tested for the antibacterial activity toward 
Micrococcus lysodeikticus by filling wells performed in Petri dishes containing trypticase soy agar (A). The 40 % 
active fraction have been also assayed at different dilution (B). 
 
 
 
 
 
bacteria. Furthermore, a detailed biochemical 
characterization of the antimicrobial activity in Hydra 
revealed the presence of conserved AMPs such as 
Hydramacin-1 and novel taxon-specific AMPs such 
as Arminin 1a and Periculin-1 which have no 
counterpart in the transcriptomes of any other 
organisms (Bosch et al., 2009). It could be possible 
to obtain, from this molecule, synthetic peptides with 
significant antibacterial activity and relatively low 
cytotoxicity to human erythrocytes, as in the case of 
stycholysin I and II (Tejuca et al., 1996), 2 pore-
forming cytolysins from the sea anemone 
Stychodactyla helianthus. 
In this paper we reported i) the presence of 
anti-Micrococcus lysodeikticus activity in acidic 
extracts from tentacles and body of A. sulcata; ii) 
the biochemical purification of the active peptide, 
and iii) its complete aa sequence revealing identity 
with Neurotoxin 2 (ATX II). 
 
Material and Methods 
 
Animals and tissues sampling  
Anemonia sulcata (Anthozoa) adults have been 
collected from Termini Imerese (Palermo, Italy) and 
maintained in oxygenated sea water at 18 °C. Acid 
extractions were performed from tentacles and body. 
Briefly, tentacle were separated from the animal 
body with a forceps and both suspended in Tris 
buffered solution (TBS, 150 mM NaCl, 10 mM Tris-
HCl, pH 7.4). After homogenization in ice bath with 
Ultra-Turrax for 5 min, 10 % acetic acid was carefully 
added. The 2 samples have been sonicated 
(Branson Model B15, Danbury, CT) 3 times for 30 
sec each, then centrifuged at 21,000xg, for 20 min at 
4 °C. Protein content of both supernatants was 
determined using the NanoDrop ND-1000 
spectrophotometer. 
Antibacterial assays 
Solid phase elution fractions have been freeze-
dried and suspended in 50 μl sterile ultra pure water 
(UPW). Antibacterial activity has been tested against 
M. lysodeikticus by filling wells performed in Petri 
dishes containing 10 ml of trypticase soy agar (TSA) 
and 3 ml of 0.5 McFarland turbidity. Each well 
received 10 μl of sample and Petri dishes were 
incubated overnight at 37 °C. Diameter of clear ring 
around the wells paralleled the antibacterial activity. 
Liquid growth inhibition assay has been used to 
check for antibacterial activity in all HPLC fractions. 
Briefly, fractions were freeze-dried and suspended in 
50 μl UPW. Twenty μl aliquots were added to 20 μl of 
a suspension of M. lysodeikticus (5x106 bacteria/ml) 
in Poor-Broth nutrient medium (1 % Bactotrypton, 0.5 
% NaCl, w/v) in 96 wells microtiter plates. Bacterial 
growth was measured at A600 with a microplate 
reader Tecan (Infinite 200 M) during 16 h at 37°C. 
Minimal inhibitory concentration (MIC) was obtained 
by testing serial doubling dilutions of selected 
purified peptide in liquid growth inhibition assay as 
above and corresponded to the lowest concentration 
that caused 100 % growth inhibition. Minimal 
bactericidal concentration (MBC) was determined by 
plating the contents of the first 5 wells with no visible 
growth of bacteria onto TSA Petri dishes. The lowest 
concentration that prevented any colony formation 
unit (CFU) as observed after 18 h incubation at 37 
°C corresponded to the MBC. 
 
Solid phase extraction and reversed phase HPLC 
purification 
Tentacles and body acid extracts were loaded 
onto Sep-Pak C8 Vac cartridges (Waters 
Associates) equilibrated with acidified water (0.05 % 
TFA in UPW). After washing with acidified water, 
three successive elutions were performed 
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Fig. 2 Tentacles and body acid extracts of Anemonia sulcata were loaded onto solid phase column (Sep-Pak C8). 
Minimum inhibition concentration of the 40 % active acetonitrile fraction was assayed toward Micrococcus 
lysodeikticus obtained after incubation in the microplate reader TECAN for 16 h at 37 °C. The data obtained show 
an antibacterial activity at concentrations up to 0.244 mg/ml.  
 
 
 
 
 
successively with 50 ml of 10, 40 and 80 % 
acetonitrile in acidified water. Fractions were freeze-
dried and reconstituted with UPW. As the bulk of the 
antimicrobial activity was detected in the 40 % 
fraction, only this fraction was submitted to reversed 
phase HPLC on a silica column C18 Interchrom 
UP5ODB-25QS (250x4.6 mm). Elution of the 50 μl 
sample was performed with a linear gradient of 0 - 
60 % acetonitrile in acidified water over 60 min at a 
flow rate of 0.5 ml/min. Fractions corresponding to 
absorbance peaks detected at both 280 and 225 nm 
were collected in polypropylene tubes, freeze dried, 
reconstituted in UPW and tested for anti-M. 
lysodeikticus activity by the liquid growth inhibition 
assays described above. Active fractions were then 
purified on the same reversed phase column, with a 
linear gradient from 20 - 60 % acetonitrile in 
acidified water at a flow rate of 0.5 ml/min. Each 
collected peak was freeze-dried, reconstituted in 
UPW and tested for anti-M. lysodeikticus activity. 
Mass spectrometry 
The molecular mass of the active peak content 
was determined by matrix-assisted laser 
desorption/ionization time-of-flight mass 
spectrometry with an Ultraflex TOF/TOF (Bruker 
Daltonics). The 2,5-dihydroxybenzoic acid (DHB) 
matrix was prepared in Acetonitrile/Ultrapure 
Water/TFA (20/80/0.1 %) for a final concentration of 
5 mg/mL. One µL of sample dissolved in 0.1 % TFA 
was mixed with 1 μL of the matrix solution on the 
steel target and dry in ambient air. The calibration 
was performed with five peptide standards: 
angiotensin II (MH+ = 1046.54), angiotensin I (MH+ 
= 1296.68), Neurotensin (MH+ = 1672.91), ACTH 
clip 1-17 (MH+ = 2093.08) and ACTH clip 18 - 39 
(MH+ = 2465.19). The data are acquiring with the 
flexControl software (version 3.3.108.0) in reflector 
mode and with an accelerating voltage in the ion 
source of 25 kV. Spectrum was analyzed with the 
flex Analysis software (version 3.3.80.0). 
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Fig. 3 Reversed phase HPLC separation of the tentacles of Anemonia sulcata. After pre-purification by solid 
phase extraction, the active material present in the fraction eluted with 40 % acetonitrile was analyzed on an silica 
column C18 INTERCHROM UP5ODB-25QS 250x4.6mm; with a hydrophobic chain of 18 carbon atoms column. 
Elution was performed with a linear gradient (dotted line) from 0 to 60 % acetonitrile in acidified water (0.05 % 
trifluoroacetic acid) over 60 min at a flow rate of 0.5 ml/min. Absorbance peaks were monitored at 225 and 280 
nm (blue and black full line respectively). Histograms show the antibacterial activity of the peaks toward 
Micrococcus lysodeikticus. 
 
 
 
 
 
Amino acid sequencing 
The peptide is deposited on a glass fiber disc 
pre-coated with Biobren Plus (Applied Biosystems). 
The dried disc is introduce into a Procise P494 
automated protein sequencer (Applied Biosystems). 
The amino acids are determinate by multiple cycles 
of automated Edman degradation coupled on-line to 
a microgradient system (Model 140C) and to a 
HPLC PTH-amino acid analyzer (model 785A). The 
amino acid sequence of the peptide, deduced from 
the chromatograms generated by the acquisition 
data, was compared to sequences in 
UniProtKB/Swiss-Prot public protein sequence 
databases using Blast tool from NCBI Protein Blast 
website. 
 
In Silico analysis  
The in silico analysis allowed to determine which 
of the two neurotoxins purified had higher probability 
of being a factor antimicrobial. The database of 
prediction used were: APD; The Antimicrobial 
Peptide Database, CAMP; Collection of Antimicrobial 
Peptides and AMPA; (Wang and Wang, 2004; Shaini 
et al., 2009; Torrent et al., 2009, 2012). APD: The 
Antimicrobial Peptide Database is a site prediction 
based on two characteristic indices for the 
determination of antimicrobial power: Wimley-White 
hydrophobicities and Boman Index (Wang and 
Wang, 2004). Wimley-White hydrophobicities is a 
scale of hydrophobicity (Kcal/mol) which defines the 
relative hydrophobicity of amino acid residues, the 
more positive is the value of this index, the more 
hydrophobic amino acids are located in that region of 
the protein. This scale is commonly used to predict 
the transmembrane alpha-helices of membrane 
proteins (White and Wimley, 1999). The Boman 
Index (potential protein binding) is defined as the 
sum of the free energies of the side chains of amino 
acid residues divided by the total number of amino 
acid residues. A low value (≤ 1) indicates that the 
peptide has a higher antibacterial activity without 
many side effects, while a higher value (2,50 - 3,00) 
indicates that the peptide is multifunctional with 
activity similar to hormones (Boman, 2003). The 
possibility of an alignment (ClustalW2) for the 
structure homology was also verified using SWISS-
MODEL. 
 
Results 
 
Purification of AMP from the tentacles of A. sulcata 
antibacterial activity of the SEP PAK products 
The 10, 40 and 80 % acetonitrile (ACN) fractions 
of the A. sulcata tentacle obtained through SEP PAK 
were tested to evaluate the antibacterial activity. 
Preliminarily was determined the protein 
concentration of the same fractions, which showed a 
higher amount of protein in the fraction of 40 % ACN 
(7.83 ± 2 mg/ml) compared to the 10 % ACN fraction 
(0.98 ± 0.12 mg/ml) and a minimum amount in the 
protein fraction to 80 % (0.20 ± 0.09 mg/ml). 
The fractions were tested against different 
bacterial strains, highlighting specific antibacterial 
activity towards M. lysodeikticus. The activity was 
found only in the fraction at 40 % acetonitrile and 
was highlighted significant activity up to a dilution of 
1/10 (Fig. 1). 
Following assays of samples on 96-well plate 
towards M. lysodeikticus and subsequent 
incubation in the microplate reader TECAN for 16 h 
at a temperature of 37 °C, the data obtained show 
an antibacterial activity at concentrations up to 0.244 
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Fig. 4 Profiles of separation of the fraction 4 and fraction 5 of the tentacles of Anemonia sulcata obtained by 
reverse phase chromatography with a gradient of acetonitrile from 20 to 60 % in acidified water (0.05 % 
trifluoroacetic acid) over 60 min at a flow rate of 0.5 ml/min. Absorbance peaks were monitored at 225 and 280 
nm (blue and black full line respectively). Histograms show peaks active toward Micrococcus lysodeikticus. 
 
 
 
 
 
mg/ml for the tentacles and antibacterial activity at 
concentrations up 0.436 mg/ml for the body, showing 
a higher potency of the extract sprawling respect to 
the body (Fig. 2). At lower concentrations it has an 
exponential bacterial growth also confirmed by 
subsequent testing of the same samples on petri 
dishes. 
 
Reverse phase chromatography 
The active molecules of the 40 % eluate were 
submitted to reversed phase HPLC and eluted with a 
gradient of 0 - 60 % acetonitrile, yielding the 
chromatogram shown in Figure 3. The graphs show 
a series of peaks from 30 min of entering the 
sample. All peaks were collected and assayed to M. 
lysodeikticus to try to identify potential antimicrobial 
factors. The assays show a high antibacterial activity 
in peaks collected between 34 and 46 min named 
fraction 1, 2, 3, 4, 5 and 6 (Fig. 3). 
All the fractions which show high antibacterial activity 
were further purified by reverse phase 
chromatography with a gradient of acetonitrile from 
20 to 60 %. The fractions 2 and 3 purified further 
show no significant peaks (data not shown), on the 
contrary fractions 4 and 5 show several peaks and in 
both fractions there is a single peak showing 
antimicrobial activity towards M. lysodeikticus (Fig. 
4). 
 
Mass spectrometric analysis and sequencing 
The peak of fraction 5, which is found to be the 
most pure, was analyzed by mass spectrometry and 
sequencing. 
The mass spectrometric analysis showed the 
presence of two peptides, the first from the molecular 
weight of 4946,299 Da present preponderantly and 
second, present in traces, from the molecular weight 
of 4808.174 (Fig. 5). 
The sequencing by the method of Edman 
detecting the presence of Neurotoxin 2 (ATX-II) 
(Wunderer et al., 1976) specific for the sodium 
channel with theoretical molecular weight of 4945.30 
Da in addition a small amount of Blood depressing 
substance (BDS II) (Doppelfeld et al., 1985; Diochot 
et al., 1998) specific for potassium channels by the 
PM of 4773.12 Da was also present (Table 1). These 
results are in agreement with the results of mass 
spectrometry weight. 
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Fig. 5 MALDI-TOF mass spectrum of fraction 5 using the matrix 2,5-DHB in reflectron mode. The peak obtained 
microsequence of ATX II is showed in the box. 
 
 
 
 
 
In silico analysis 
The in silico analysis showed in table 1 allowed 
to determine the antimicrobial potential of ATX II. 
The predicting database used were The 
Antimicrobial Peptide Database (APD), Collection of 
Antimicrobial Peptides (CAMP) and Antimicrobial 
Sequence Scanning System (AMPA) (Wang and 
Wang, 2004; Shaini et al., 2009; Torrent et al., 2009, 
2012). 
APD is based on two characteristic indices for 
the determination of antimicrobial power: Wimley -
White hydrophobicities and Boman Index (Wang and 
Wang, 2004). 
The hydrophobicity index is positive for ATX II 
and negative for BDS II, indicating that for the first 
molecule of the amino acids located in that region of 
the protein are more hydrophobic and therefore there 
is a greater potential that can play an antimicrobial 
function. 
Even the Boman Index attaches a greater 
potential antimicrobial ATX II, in fact a lower value of 
this index (≤ 1) indicates that the peptide has a 
higher antibacterial activity. 
Furthermore, aligning our sequences with those 
present in this database, ATX II showed a similarity 
of 35 % with active peptides towards Gram + , Gram- 
and fungi , while BDS II showed a similarity of 35 % 
towards Gram + and Gram -. 
CAMP uses a algorithm prediction, Support 
Vector Machine (SVM), incorporated into the 
database, which also gives a probability score (0 - 1) 
for the prediction. The higher the probability, the 
greater the possibility that the prediction may be 
correct (Shaini et al., 2009). According to this 
database both molecules, ATX II and BDS II, have 
the potential to be antimicrobial peptides, with a 
higher probability for ATX II. 
AMPA uses of graphs showing the antimicrobial 
profile for the sequence of entry (s) and computes 
the probability of finding stretches of sequence in 
non-antimicrobial proteins (Torrent et al., 2009, 
2012). For BDS II is provided a probability value of 1 
% to find the section provided in a non-antimicrobial 
protein. 
Following the analysis in silico we can conclude 
that both molecules have a high probability of being 
factors and antimicrobials, this probability, it appears 
to be greater for ATX II. 
Subsequently, all the toxins of A. sulcata were 
analyzed by prediction database, showing that 
neurotoxins specific for sodium channels have a 
higher chance of being antimicrobial factors 
compared to neurotoxins specific for potassium 
channels and, confirming that ATX-II presents all the 
characteristics suitable to be a factor antimicrobial 
together with ATX-V, another neurotoxin specific for 
the sodium channels (Table 1). 
Using SWISS-MODEL was verified the 
possibility of an alignment (ClustalW2) for the 
homology of structure between ATX II (target) and 
the chain A of the Human Beta-defensin 2 (1fd3A) 
(Template). The quality of the model was verified by 
two programs: Anolea and Qmean. 
The alignment of the two sequences was also 
analyzed with the program DSSP which defines the 
secondary structure, the geometric characteristics and 
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Table 1 Summary of the antimicrobial properties of all the known Anemonia sulcata neurotoxins 
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The parameters indicated in red are congruent with neurotoxin antimicrobial properties. 
Toxin 
Uniprot/Genbank 
Accession 
number 
Toxin family Target 
Wimley-White 
hydrophobicities 
(Kcal/mol) 
APD 
Total 
hydrophobic 
ratio(%) 
APD 
Net 
charge 
APD 
Boman Index 
(Kcal/mol) 
APD 
AMP 
probability 
CAMP 
No-AMP 
stretch (%) 
AMPA 
ATX-I P01533/ - Type I NaV1 2.54 39 +2 1.15 0.988 0 
ATX-II P01528/ - Type I 
Binds to site 3. 
DmNaV, SCN2A 
and SCN5A 
1.39 38 +2 0.72 0.983 0 
ATX-III P01535/ - 
Sea anemone 
short toxin family NaV1 -0.02 33 +1 0.94 0.984 18 
ATX-V P01529/ - Type I NaV 1.54 39 +3 0.76 0.979 0 
SA5 II P10280/ - 
Cnidaria kunitz-
type proteinase 
inhibitor/Type II 
- 14.87 32 +4 2.28 0.889 10 
kalicludin-1 Q9TWG0/ - 
Cnidaria kunitz-
type proteinase 
inhibitor/Type II 
KV1.2 13.97 32 +4 2.66 0.579 14 
kalicludin-2 Q9TWF9/ - 
Cnidaria kunitz-
type proteinase 
inhibitor/Type II 
KV1.2 14.51 32 +8 3.01 0.827 5 
kalicludin-3 Q9TWF8/ - 
Cnidaria kunitz-
type proteinase 
inhibitor/Type II 
KV1.2 13.47 33 +4 2.49 0.860 3 
BDS-I P11494/ - 
Cnidaria kunitz-
type proteinase 
inhibitor/Type II 
KV3.1, 3.2, 
3.4 -2.73 34 +3 0.81 0.969 1 
kaliseptin Q9TWG1/ - Type I KV1.2 10.76 38 +5 2.08 0.918 16 
BDS-II P59084/ - Type III 
KV3.1, 3.2, 
3.4 -1.19 34 +2 0.95 0.928 1 
orientation of the protein, showing the presence of 
alpha helices (h) and folds (s) common to the two 
molecules. 
Although the structural model resulting show of 
the regions of incompatibility between the two 
molecules there are large regions compatible with a 
common structure in terms of energy (Anolea and 
Qmean) both as a possible presence of secondary 
structures common. 
 
Discussion 
 
Cnidarian are a source of neurotoxins acting on 
sodium and potassium ion channels (Yamaguchi et 
al., 2010) or cytotoxic pore forming molecules 
(Maisano et al., 2013; Parisi et al., 2014). 
The sea anemone A. sulcata, is exposed to 
attack from predators with the tentacle always 
exposed. Moreover, A. sulcata captures food actively 
wide spectrum of prey (Chintiroglou and Koukouras, 
1992), that causes frequently the rupture of the soft 
tentacle with consequent bacterial infection. Thus, 
the chemical arsenal of A. sulcata represents the 
preferred strategy to survive in such a habitat mainly 
with the produced neurotoxin together with 
antimicrobial molecules (Moran et al., 2008). 
The present study describes isolation and 
characterization of a neurotoxins that possess also 
antibacterial activity against M. lysodeikticus. This 
neurotoxin was characterized and purified from the 
tentacle of an Anthozoa A. sulcata by acid extraction, 
HPLC purifications mass spectroscopy and 
antibacterial assays. 
More than fifty toxins specific for sodium 
channels classified on the basis of amino acid 
sequence (Homma and Shiomi, 2006). The types 1 
and 2 are composed of a number of amino acid 
residues between 46 and 49, the type 3 is instead 
characterized by polypeptide chains ranging from a 
minimum of 27 to a maximum of 32 amino acid 
residues (Homma and Shiomi, 2005). A common 
origin of animal AMPs and toxins seems to be 
biologically expedient. Despite the difference of their 
affected targets-the membranes of micro - or 
macroorganisms, functioning conditions of both 
peptide groups impose similar requirements to 
molecule structure and its physicochemical 
characteristics, such as cationicity, often coupled 
with amphipathicity, resistance to enzymatic 
hydrolysis, and overall compactness. 
The best-known examples of these are the 
pardaxins of fish that were originally purified on the 
basis of their toxic, anti-predatory activity (Lazarovici 
et al., 1986) yet have similar antibacterial potencies 
to the amphibian magainins and insect cecropins 
(Oren and Shai, 1996). 
The way these molecules are engaged in 
defense and aggression mechanisms includes 
temporary accumulation in reservoirs of specialized 
cells followed by eventual release to extracellular 
environment. It would be logical to assume that 
similar mechanisms of processing and secretion may 
be involved in both cases requiring the presence of 
the same signal sequences within peptide 
precursors. Overlapping of biological properties, 
along with the sequence homology, might be a 
consequence of divergent evolution from a common 
ancestor (Ovchinnikova et al., 2006). 
The neurotoxin ATX II is a type 1 sodium 
channel toxin and consists of 47 amino acid 
residues, linked by three disulfide bridges. ATX II 
specifically binds to the sodium channel, thus 
delaying its inactivation during signal transduction. 
This molecule has a strong effect on crustaceans 
and insects and a weaker effect on mammals. The 
research about these type of toxins specific for 
sodium channels have been thoroughly investigated 
also because they constitute a major fraction of the 
venom (Moran et al., 2009). 
Nature thus seems to ‘mix and match’ useful 
domains to create AMPs (Smith et al., 2010) that 
could have mechanisms to destroy their targets 
compatible with other biological function. Cnidarians 
have impressive strategies for locomotion, feeding 
and reproduction. Its detailed study may allow better 
understand the diversification of the molecular 
novelties of these unique metazoan species (Frazao 
et al., 2012). In the light of the obtained results, we 
can consider ATX II as a neurotoxin having 
antimicrobial peptide and functional characteristics. 
This multi-functionality can be an optimal strategy for 
survival by allowing these animals to be active 
predators through the production of neurotoxins and 
to resist bacterial infections caused eventual rupture 
of the tentacles through the functionality by 
antimicrobial peptides. 
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